NORTRIPTYLINE HCL — Class II drug recall D-828-2014
Terminated recall by Aidapak Services, LLC, reported 2014-01-29, distributed in AZ, CA, OR, WA. Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 50 mg may have potentially been mislabeled as one of the fo
| Recall number | D-828-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aidapak Services, LLC, Vancouver, WA, United States |
| Recall initiated | 2013-07-02 |
| Classified | 2014-01-20 |
| Reported by FDA | 2014-01-29 |
| Terminated | 2014-02-07 |
| Distributed | AZ, CA, OR, WA |
| Quantity | 200 capsules |
| Reason classes | labeling |
| Expiration dates | 2014-05-01, 2014-05-16 |
Product
NORTRIPTYLINE HCL, Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081201.
Reason for recall
Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 50 mg may have potentially been mislabeled as one of the following drugs: ROSUVASTATIN CALCIUM, Tablet, 5 mg, NDC 00310075590, Pedigree: AD21811_10, EXP: 5/2/2014; LIOTHYRONINE SODIUM, Tablet, 5 mcg, NDC 42794001802, Pedigree: AD46414_38, EXP: 5/16/2014.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-828-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.